Importance of biologically active agents over other therapies in Rheumatoid Arthritis- a review
| bracu.degree.level | Undergraduate | |
| bracu.type.group | Student Works | |
| datacite.rights | Open Access | |
| dc.contributor.advisor | Tahsin, Faria | |
| dc.contributor.author | Mehreen, Elnaj | |
| dc.contributor.department | Department of Pharmacy | |
| dc.date.accessioned | 2021-07-05T14:53:13Z | |
| dc.date.available | 2021-07-05T14:53:13Z | |
| dc.date.copyright | 2021 | |
| dc.date.issued | 2001-01 | |
| dc.description | Cataloged from PDF version of thesis report. | |
| dc.description | Includes bibliographical references (pages 30-35). | |
| dc.description | This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021. | en_US |
| dc.description.abstract | Rheumatoid arthritis (RA) is an autoimmune disease which causes chronic inflammation and joint pain and will eventually lead to serious damage in the bone and cartilage of the affected joint. Many people around the world develop RA in older age. RA usually affect the joints like- elbow, shoulder and metacarpophalangeal joints in the patient. Previously with conventional therapy only the symptoms of RA was treated. However, now-a-days with biological disease-modifying anti rheumatic drugs (bDMARDs) the reason for causing RA is treated by targeting the biological receptors like- TNF-alpha, IL-1 and IL-6 etc. In this review article we are reviewing the benefits of using biological disease-modifying anti rheumatic drugs over the conventional treatment of RA. | en_US |
| dc.description.degree | Bachelor of Pharmacy | |
| dc.description.statementofresponsibility | Elnaj Mehreen | |
| dc.format.extent | 35 pages | |
| dc.identifier.other | ID 14346023 | |
| dc.identifier.uri | http://hdl.handle.net/10361/14735 | |
| dc.language.iso | en | en_US |
| dc.publisher | BRAC University | en_US |
| dc.rights | Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. | |
| dc.subject | Rheumatoid arthritis | en_US |
| dc.subject | TNF-alpha | en_US |
| dc.subject | interleukin | en_US |
| dc.subject | Disease-modifying anti rheumatic drugs | en_US |
| dc.subject | Biological disease-modifying anti rheumatic drugs | en_US |
| dc.subject.lcsh | Antirheumatic agents. | |
| dc.title | Importance of biologically active agents over other therapies in Rheumatoid Arthritis- a review | en_US |
| dc.type | Thesis | en_US |